The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as pr
-
Page/Page column 59-60; 153
(2008/12/07)
More Articles about upstream products of 1042032-03-0